Hyperuricemia and Adverse Outcomes in Cardiovascular Disease: Potential for Therapeutic Intervention

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.5, 2003-01, pp. : 309-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Paraoxonase 1 Activity in Cardiovascular Disease: Potential for Therapeutic Intervention

By Michael I. Mackness Paul N. Durrington Bharti Mackness

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 211-217

Adis International

Access to resources Recommend Favorite

Angiogenesis in Cardiovascular Disease: Current Status and Therapeutic Potential

By Sellke F.W. Simons M.

Drugs, Vol. 58, Iss. 3, 1999-09 ,pp. : 391-396

Adis International

Access to resources Recommend Favorite

The therapeutic potential of neuropeptide Y in cardiovascular disease

By Munglani R. Hudspith M.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 437-445

Informa Healthcare

Access to resources Recommend Favorite

New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention

Current Drug Targets, Vol. 19, Iss. 16, 2018-12 ,pp. : 1968-1979

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Treatment of Hyperuricemia to Prevent Cardiovascular Outcomes: Are We There Yet?

By Gaffo Angelo L. Saag Kenneth G.

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 1, 2012-02 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite